Precision System Science Co (7707.T) Aktie Kurs

Precision System Science Co Kurs

LUKKET
232,00
​
Markedet lukket

Omsætningen er vokset med 1,8 % om året de seneste 19 år til 5,22 Mrd. JPY. Indtjening pr. aktie er vokset med 7,4 % om året de seneste 17 år. Precision System Science Cos nettoavance ligger på 7,6 %, op fra 0,6 % for flere år siden. Precision System Science Co har i øjeblikket et direkteafkast på omkring 2,16 %. Udlodningsandelen er omkring 18 % af indtjeningen.

Precision System Science Co aktiekurs

Hent disse data via Eulerpool API

Precision System Science Co aktie og aktieanalyse

Precision System Science Co Ltd er en førende virksomhed inden for medicinsk forskning og diagnostik, grundlagt i Japan i 1989. Virksomheden har hovedkvarter i Chiba, Japan, og driver afdelinger i Europa, USA og Asien. Forretningsmodellen er fokuseret på at levere et bredt udvalg af instrumenter, udstyr og tjenester til forskning, diagnostik og terapi inden for medicinalbranchen. Virksomheden designer og producerer egne produkter og tilbyder desuden skræddersyede løsninger til kunderne. Den er opdelt i forskellige divisioner, herunder instrumenter og udstyr til molekylærbiologi og diagnostik, celleanalyse, mikroskopi og prøveforarbejdning. De tilbyder produkter såsom PCR-systemer, qPCR-systemer, automatiserede systemer til prøveforberedelse og RNA-isoleringskits til molekylærbiologi og diagnostik. De producerer også celletællingssystemer, flowcytometere, højhastighedsbilledsystemer og multi-well pladelæsere til celleanalyse. I mikroskopidivisionen fremstiller virksomheden kvalitetsfluorescensmikroskoper og dekonvolutionsmikroskoper til analyse af protein- og DNA-molekyler, sygdomsdiagnostik, lægemiddeludvikling osv. I divisionen for prøveforarbejdning producerer de automatiske stationer, der bruges til at forberede prøver til genomik- og proteomikanalyse. Virksomheden er også beskæftiget med forskning og udvikling af medicinsk udstyr og instrumenter for at forbedre kvaliteten af medicinsk diagnostik og terapi. Et eksempel på et succesfuldt produkt er qPCR-termocycleren MIQE, der anvendes til diagnose og terapi af sygdomme som kræft. Precision System Science Co Ltd har spillet en betydelig rolle i kampen mod COVID-19-pandemien ved at producere testkits til diagnose og tilbyde avancerede PCR-systemer til masse-testning. De er engageret i løbende innovation og forbedring af deres produkter og tjenester for at imødekomme den medicinske branches skiftende behov. Med deres stærke tilstedeværelse og dedikation til at levere banebrydende og innovative produkter og tjenester, vil de fortsat være en stor spiller på det globale marked for medicinsk udstyr og instrumenter.

Hyppigt stillede spørgsmål om Precision System Science Co-aktien

The business model of Precision System Science Co Ltd is focused on providing innovative solutions in the field of life science research and diagnostics. The company specializes in developing and manufacturing advanced instruments, equipment, and consumables for genetic testing, nucleic acid purification, and molecular biology applications. Precision System Science Co Ltd aims to contribute to scientific advancements and improve healthcare outcomes through its cutting-edge technologies and products. The company's commitment to continuous innovation and high-quality solutions has made it a leading player in the industry.

Precision System Science Co Ltd is primarily active in the life sciences and healthcare industries.

The main competitors of Precision System Science Co Ltd in the market are companies like Thermo Fisher Scientific Inc., Beckman Coulter, Inc., and Roche Diagnostics.

Precision System Science Co Ltd (PSS) is a renowned company in the field of life sciences and biotechnology. Established in 1986, PSS has since been dedicated to developing innovative solutions and high-quality products for the life sciences industry. With its headquarters in Japan, PSS has expanded globally, with subsidiaries and distributors across various countries. The company focuses on providing advanced technologies, including PCR instruments, nucleic acid extraction systems, automated liquid handling systems, and more. PSS's commitment to research and development has led to breakthroughs in molecular biology, diagnostics, and genomics. Today, Precision System Science Co Ltd continues to be a leading force driving advancements in the life sciences sector.

Precision System Science Co Ltd has achieved several significant milestones. It has successfully established itself as a key player in the life science industry, offering innovative solutions and products. The company has made remarkable progress in the field of genomic research and development, contributing to advancements in precision medicine. Precision System Science Co Ltd has also achieved commendable success with its automated laboratory equipment, revolutionizing the efficiency and accuracy of scientific experiments. Furthermore, the company has expanded its global presence, forging strategic partnerships and collaborations with renowned institutions and multinational corporations. These accomplishments demonstrate Precision System Science Co Ltd's commitment to technological excellence and its position as a leader in the industry.

Precision System Science Co Ltd is primarily present in Japan.

Precision System Science Co Ltd (PSS) is a leading company in the field of life sciences and diagnostics. Their values revolve around innovation, quality, and customer satisfaction. PSS is committed to providing reliable and cutting-edge solutions that meet the evolving needs of the scientific community. With a corporate philosophy centered on integrity and transparency, PSS strives to contribute to society through advancements in healthcare and research. By continuously investing in research and development, PSS aims to deliver state-of-the-art technologies and services that empower their customers to achieve breakthroughs in their respective fields.

7 analytikere vurderer i øjeblikket Precision System Science Co-aktien: 0 anbefaler køb, 3 hold og 4 salg.

Omregnet til den aktuelle valutakurs handles Precision System Science Co-aktien til 1,31 EUR (232,00 JPY).

Precision System Science Co Ltd (PSS) is a Japanese company specializing in the development, manufacturing, and distribution of systems for molecular biology research and diagnostics. The company's business model includes several divisions, including consumables, instruments, services, and licensed products. In the consumables division, PSS offers a wide range of items needed for conducting molecular biology experiments. These include products such as PCR reagents, DNA extraction kits, probes and primers, electrophoresis kits, antibodies and proteins, cell culture media, and plate systems. PSS aims to provide highly effective technologies and reagents at every step of DNA analysis and manipulation to ensure precision and reproducibility of research results. In the instruments division, PSS offers automated systems that facilitate the work of laboratory personnel. Products include pipettors, thermocyclers, sample preparation stations, and cell manipulators. These instruments improve workflows and reduce human errors, resulting in higher efficiency and accuracy in experiment execution. PSS has gained recognition in the field of automated systems through the development of innovative high-throughput systems and analytical platforms. PSS also offers a variety of services, including customer support, training, repairs, and validation services. Through its extensive services, PSS ensures that customer performance is enhanced through highly efficient and reliable processes. Licensing of technologies and products is also an important component of PSS's business model. The company collaborates closely with companies and institutions to commercialize their technologies and distribute their products globally. PSS focuses on the development of products and technologies that align with the needs and advancements in molecular biology research and diagnostics. The company has established itself as a pioneer in the field of DNA manipulation and analysis, underscored by a strong research and development department. PSS's products are used by scientists and researchers worldwide to make groundbreaking discoveries and advance knowledge in biological science. Overall, PSS aims to strengthen and expand its market position by creating an increasingly diverse product range and a stronger presence in the global market. The company is committed to understanding and meeting customer needs in order to develop ever more innovative products and technologies. PSS is a company focused on promoting scientific knowledge and advancements worldwide while always keeping its environmental and societal responsibilities in mind.

-omsætningen for Precision System Science Co er 5,22 Mrd. JPY. Dette tal er baseret på aktuelle finansielle data og afspejler virksomhedens forretningsydeevne.

-overskuddet for Precision System Science Co er 394,87 Mio. JPY. Nettooverskuddet afspejler virksomhedens rentabilitet efter fradrag af alle udgifter.

Pris-til-indtjening-forholdet (P/E) for Precision System Science Co er i øjeblikket 16,10. P/E-forholdet sammenligner den nuværende aktiekurs med indtjeningen pr. aktie og hjælper investorer med at vurdere værdiansættelsen af Precision System Science Co-aktien.

Pris-til-salgs-forholdet (P/S) for Precision System Science Co er i øjeblikket 1,22. P/S-forholdet sammenligner markedskapitalisering med årlig omsætning og fungerer som en værdiansættelsesmetrik for Precision System Science Co-aktien.

AlleAktien-kvalitetsscore for Precision System Science Co er 3/10.

ISIN for Precision System Science Co er JP3833400009. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.

Tickeren for Precision System Science Co er 7707.T. Tickersymbolet bruges til at handle Precision System Science Co-aktier på børsen.

Fair værdiTerminal
208,80 JPY
Over-/underværdieringTerminal
Fair værdieret
Sektor
Industri
Værktøjer & Tjenester til Biovidenskab
Antal aktier
Medarbeidere
Omsætning pr. medarbejder
31,43 Mio. JPY
Omsætningsvækst Ø5 år
EBIT-vækst Ø5 år
Resultatvækst Ø5 år
Hjemmeside pss.co.jp
Land
Valuta
JPY
Børsintroduktion
1. feb. 2001
ISIN
JP3833400009
CUSIP
J6397V109
SEDOL
6318246
Markedsværdi
52-ugers interval
AAQS
3 / 10
PEG-forhold
—
P/E-forhold
P/Ee 2027
—
P/S
P/Se
—
EV/EBIT
29,99
K/B-forhold
1,56
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
7,72 %
Sidst opdateret 10. okt. 2026, 15.32

Precision System Science Co FIGI

7707:JP · BBG000F6HFK57707:JT · BBG000F6HG327707:JJ · BBG000F6HNF47707:JE · BBG000F6HQP67707:JI · BBG000F6HR29PCNEF:US · BBG000GPV458PCNEF:PQ · BBG002J8Z197PCNEF:UV · BBG002J8Z1C37707:JU · BBG002QKC0H07707:JW · BBG00875H3C57707:JV · BBG0193R9BF6